PlainPharmaWatch

CMS Open Payments · Tool

Optimotion Implants, LLC vs Rhythm Pharmaceuticals, Inc.

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Optimotion Implants, LLC has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 4,777, versus 449 for the other company. Its single largest recorded recipient represents 57.3% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Optimotion Implants, LLC
HHI 4,777 · top recipient 57.3%
Ranked #389 of 1,838 companies by HHI
Rhythm Pharmaceuticals, Inc.
HHI 449 · top recipient 11.3%
Ranked #1,330 of 1,838 companies by HHI

Payment Overview

Total Payments
$8.0M
% of Industry
0.1%
Transactions
10
Avg per Transaction
$796.0K
Recipients
6
Avg per Recipient
$1.3M
Payment Types
2
Top Payment Type
Consulting Fee
Total Payments
$8.1M
% of Industry
0.1%
Transactions
3,195
Avg per Transaction
$2.5K
Recipients
1,007
Avg per Recipient
$8.0K
Payment Types
6
Top Payment Type
Honoraria

Highlighted values indicate the higher figure for each metric.

Total payments compared

Optimotion Implants, LLC vs Rhythm Pharmaceuticals, Inc. - total reported payments in CMS Open Payments PY2024

Rhythm Pharmaceuticals, Inc.$8.1MOptimotion Implants, LLC$8.0M

General Payment Types Breakdown

Category shares use each company's General Payments total, not the all-tracks (General + Research + Ownership) hero figure.

Optimotion Implants, LLC

Consulting Fee $3.0K

57.3%

Travel and Lodging $2.2K

42.7%

Rhythm Pharmaceuticals, Inc.

Honoraria $68.7K

38.8%

Consulting Fee $37.1K

21.0%

Food and Beverage $27.5K

15.5%

Travel and Lodging $22.6K

12.8%

Grant $20.0K

11.3%

Education $1.2K

0.7%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Optimotion Implants, LLC

  1. 1

    DAVID CHEONG

    $3,000.00 · 1 txns

  2. 2

    Vuong Nguyen

    $2,021.36 · 3 txns

  3. 3

    AMANDA ROGAN

    $131.09 · 1 txns

  4. 4

    MARILYNE ETIENNE

    $86.18 · 1 txns

Rhythm Pharmaceuticals, Inc.

  1. 1

    Childrens Hospital Colorado

    $20,000.00 · 1 txns

  2. 2

    JOSE GAMEZ

    $14,591.31 · 21 txns

  3. 3

    JENNIFER R PAISLEY

    $13,804.14 · 15 txns

  4. 4

    JAMES SWAIN

    $11,660.18 · 7 txns

  5. 5

    VIDHU THAKER

    $9,430.61 · 13 txns

Summary Comparison

Metric Optimotion Implants, LLC Rhythm Pharmaceuticals, Inc.
Total Payments $8.0M $8.1M
% of Industry Total 0.1% 0.1%
Transaction Count 10 3,195
Avg per Transaction $796.0K $2.5K
Recipient Count 6 1,007
Avg per Recipient $1.3M $8.0K
Payment Type Count 2 6
Top Payment Type Consulting Fee Honoraria

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.